Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014 | Zendy

Kathleen Chiotos | Zendy; Rachael Ross | Zendy; Jennifer Han | Zendy; Matthew Miller | Zendy; Jeffrey S. Gerber | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014

Author(s) -

Kathleen Chiotos,

Rachael Ross,

Jennifer Han,

Matthew Miller,

Jeffrey S. Gerber

Publication year - 2017

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx039

Subject(s) - tigecycline , medicine , polymyxin , carbapenem , intensive care medicine , colistin , polymyxin b , antibiotics , emergency medicine , pediatrics , microbiology and biotechnology , biology

We characterized use of the carbapenems, polymyxins, and tigecycline in United States children’s hospitals between 2010 and 2014. We found substantial variability in use across hospitals and overall decreased use over time. Most polymyxin and tigecycline use occurred in cystic fibrosis patients, and appendectomy was a common indication for carbapenem therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research